| Bedside monitoring to adjust antiplatelet therapy for coronary stenting JP Collet, T Cuisset, G Rangé, G Cayla, S Elhadad, C Pouillot, P Henry, ... New England Journal of Medicine 367 (22), 2100-2109, 2012 | 1058 | 2012 |
| Abatacept for severe immune checkpoint inhibitor–associated myocarditis JE Salem, Y Allenbach, A Vozy, N Brechot, DB Johnson, JJ Moslehi, ... New England Journal of Medicine 380 (24), 2377-2379, 2019 | 343 | 2019 |
| ST-segment elevation myocardial infarction B Vogel, BE Claessen, SV Arnold, D Chan, DJ Cohen, E Giannitsis, ... Nature reviews Disease primers 5 (1), 39, 2019 | 323 | 2019 |
| Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial JP Collet, J Silvain, O Barthélémy, G Rangé, G Cayla, E Van Belle, ... The Lancet 384 (9954), 1577-1585, 2014 | 321 | 2014 |
| Periprocedural myocardial infarction and injury in elective coronary stenting M Zeitouni, J Silvain, P Guedeney, M Kerneis, Y Yan, P Overtchouk, ... European heart journal 39 (13), 1100-1109, 2018 | 181 | 2018 |
| Antithrombotic therapy for patients with left ventricular mural thrombus B Lattuca, N Bouziri, M Kerneis, JJ Portal, J Zhou, M Hauguel-Moreau, ... Journal of the American College of Cardiology 75 (14), 1676-1685, 2020 | 162 | 2020 |
| Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis E Ammirati, L Lupi, M Palazzini, NS Hendren, JL Grodin, CV Cannistraci, ... Circulation 145 (15), 1123-1139, 2022 | 151 | 2022 |
| High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study J Silvain, G Cayla, JS Hulot, J Finzi, M Kerneis, SA O'Connor, ... European heart journal 33 (10), 1241-1249, 2012 | 149 | 2012 |
| Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis A Bellemain-Appaix, M Kerneis, SA O’Connor, J Silvain, M Cucherat, ... bmj 349, 2014 | 108 | 2014 |
| Coronavirus disease 2019 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units G Hékimian, M Kerneis, M Zeitouni, F Cohen-Aubart, J Chommeloux, ... Chest 159 (2), 657-662, 2021 | 106 | 2021 |
| Long-term evolution of premature coronary artery disease JP Collet, M Zeitouni, N Procopi, JS Hulot, J Silvain, M Kerneis, D Thomas, ... Journal of the American college of cardiology 74 (15), 1868-1878, 2019 | 103 | 2019 |
| Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of … J Silvain, J Abtan, M Kerneis, R Martin, J Finzi, JB Vignalou, O Barthélémy, ... Journal of the American College of Cardiology 63 (13), 1289-1296, 2014 | 103 | 2014 |
| Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial JP Collet, E Van Belle, H Thiele, S Berti, T Lhermusier, T Manigold, ... European Heart Journal 43 (29), 2783-2797, 2022 | 96 | 2022 |
| Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial J Silvain, B Lattuca, F Beygui, G Rangé, Z Motovska, JG Dillinger, ... The Lancet 396 (10264), 1737-1744, 2020 | 95 | 2020 |
| Switching acute coronary syndrome patients from prasugrel to clopidogrel M Kerneis, J Silvain, J Abtan, G Cayla, SA O'Connor, O Barthélémy, ... JACC: Cardiovascular interventions 6 (2), 158-165, 2013 | 78 | 2013 |
| Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor: The APTITUDE Study SA O’Connor, J Amour, A Mercadier, R Martin, M Kerneis, J Abtan, ... Circulation: Cardiovascular Interventions 8 (11), e002786, 2015 | 77 | 2015 |
| Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor–associated myocarditis: a narrative review LH Lehmann, J Cautela, N Palaskas, AH Baik, WC Meijers, Y Allenbach, ... JAMA cardiology 6 (11), 1329-1337, 2021 | 74 | 2021 |
| Association of serum cholesterol efflux capacity with mortality in patients with ST-segment elevation myocardial infarction M Guerin, J Silvain, J Gall, M Darabi, M Berthet, E Frisdal, ... Journal of the American College of Cardiology 72 (25), 3259-3269, 2018 | 70 | 2018 |
| ARCTIC investigators. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial JP Collet, J Silvain, O Barthélémy, G Rangé, G Cayla, E Van Belle, ... Lancet 384 (9954), 1577-85, 2014 | 69 | 2014 |
| Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention J Silvain, LS Nguyen, V Spagnoli, M Kerneis, P Guedeney, N Vignolles, ... Heart 104 (9), 767-772, 2018 | 65 | 2018 |
